CPG
IDXX icon

Cornerstone Planning Group’s Idexx Laboratories IDXX Stock Holding History

Cornerstone Planning Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.5K Buy
122
+24
+24% +$13.5K 0.01% 336
2026
Q1 		$55.2K Sell
98
-8
-8% -$5.13K 0.01% 374
2025
Q4 		$72.9K Buy
106
+27
+34% +$18.4K 0.01% 265
2025
Q3 		$49.7K Buy
79
+4
+5% +$2.43K 0.01% 341
2025
Q2 		$48.1K Sell
75
-29
-28% -$13.9K 0.01% 246
2025
Q1 		$44.4K Buy
104
+54
+108% +$23.4K 0.01% 261
2024
Q4 		$21.4K Buy
50
+24
+92% +$10.5K 0.01% 302
2024
Q3 		$11.6K Buy
26
+1
+4% +$486 ﹤0.01% 387
2024
Q2 		$11.4K Sell
25
-21
-46% -$10.5K ﹤0.01% 411
2024
Q1 		$22.1K Sell
46
-14
-23% -$7.65K 0.01% 284
2023
Q4 		$33.3K Hold
60
– – 0.01% 241
2023
Q3 		$26.2K Sell
60
-13
-18% -$6.48K 0.01% 272
2023
Q2 		$36.7K Buy
+73
New +$35K 0.01% 301
2022
Q4 		$48.9K Buy
+103
New +$40K 0.02% 269

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Cornerstone Planning Group's IDXX Position: Q2 2026 in Review

Cornerstone Planning Group increased its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, buying an estimated $13.5K and bringing the position to 122 shares worth $66.5K. The position accounts for 0.01% of the portfolio, ranked #336.

Cornerstone Planning Group first reported a position in IDXX in Q4 2022 and has held it in 14 quarters since. The position peaked at $72.9K in Q4 2025. 724 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cornerstone Planning Group held 122 shares of Idexx Laboratories worth $66.5K as of Q2 2026.
  • Cornerstone Planning Group bought 24 Idexx Laboratories shares in Q2 2026, an estimated $13.5K.
  • Idexx Laboratories made up 0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #336 holding.
  • Cornerstone Planning Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's Idexx Laboratories position peaked at $72.9K in Q4 2025.
  • 724 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.